Therapeutic range: 4-10 mg/mL; N-acetylprocainamide: 6-20 mg/mL
Comment: Cardiovascular drug used in the treatment of venticular tachhycardia, PVC’s, paroxysmal atrial tachycardia and atrial fibrillation. To prevent the recurrence of ventricular tachycadia, PSVT, atrial fibrillation or flutter. Increased levels with cimetidine, ranitidine, β-blockers, and amiodarone
Sample: serum